Scientists found the “holy grail” gene that could one day help humans regrow limbs
Scientists studying axolotls, zebrafish, and mice have uncovered a shared set of genes that may one day help humans regrow lost limbs. By identifying powerful “SP genes” involved in regeneration, researchers discovered that disabling these genes stopped proper bone regrowth in salamanders and mice. They then used a gene therapy inspired by zebrafish biology to partially restore regeneration in mic
Spain readies for evacuations as a hantavirus-hit cruise ship heads for the Canary Islands
Spanish authorities on Friday were preparing to receive more than 140 passengers and crew members on board a hantavirus-stricken cruise ship headed for the Canary Islands.
STAT+: Roche to buy PathAI for $750 million
Roche has signed a deal to acquire PathAI to speed up its use of artificial intelligence to help pathologists diagnose diseases.
Trump reportedly plans to fire FDA Commissioner Makary
Makary's ouster would create another high-profile vacancy atop RFK Jr.'s health department.
STAT+: Capricor Therapeutics accuses Nippon Shinyaku of slow-walking plans on Duchenne drug
Capricor Therapeutics has accused Nippon Shinyaku and its U.S. subsidiary of botching the rollout of a Duchenne muscular dystrophy treatment.
New obesity discovery rewrites decades of fat science
Scientists have uncovered a surprising secret hidden inside fat cells that could reshape how we think about obesity and metabolic disease. A protein called HSL, long believed to simply release stored fat when the body needs energy, turns out to have a second job deep inside the nucleus of fat cells—helping keep those cells healthy and balanced. Even more surprising, people and mice missing this pr
As new tech, AI sweeps the marketing world, Eversana Intouch’s new CEO is ‘comfortable in the gray’
Eversana Intouch, the AI-powered marketing agency arm of Eversana, pulled seasoned advertising exec Mike Guarino to serve as its new CEO.
Opinion: I’m fighting misinformation online. False hantavirus claims follow a now-familiar playbook
The cruise ship hantavirus outbreak is serious but limited. Online, it's another story.
Former FDA leaders, pharma speak out on mifepristone
“The fundamental question is: Who gets to regulate mifepristone?”
Trump plans to fire FDA chief Marty Makary: report
President Donald Trump has approved a plan to fire FDA Commissioner Marty Makary, M.D., according to a report from The Wall Street Journal.
Lawmakers, former FDA leaders and more rally behind mifepristone as Supreme Court weighs telemedicine access to abortion pill
During the weeklong stay by the Supreme Court to temporarily restore online access to the abortion pill mifepristone after a shock appeals court decision last Friday, scores of experts, industry heavyweights and former regulators have weighed in to defend the availability of the product.
Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
Explore how targeted protein degradation is reshaping drug discovery, enabling new approaches for difficult targets and advancing novel therapeutic modalities.
Gilead cranks up Yeztugo first-year sales forecast to $1B on 'unprecedented launch trajectory'
Gilead raised its previous guidance of $800 million in revenues from the long-acting PrEP injectable Yeztugo based on a high-flying launch thus far.
Capricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma
With an FDA decision date looming for its Duchenne muscular dystrophy (DMD) treatment deramiocel, Capricor Therapeutics has filed a lawsuit against its U.S. commercial partner, NS Pharma, and its parent company, Nippon Shinyaku.
A common constipation drug shows surprising power to protect kidneys
A common constipation drug may have unexpectedly unlocked a new way to slow chronic kidney disease — a condition that affects millions and often leads to dialysis. In a clinical trial involving 150 patients, researchers found that lubiprostone, a medication normally used to treat constipation, helped preserve kidney function in people with moderate CKD. Scientists traced the effect to changes in g
Scientists discover a new way to prevent gum disease without killing good bacteria
Scientists have uncovered a surprising way to influence the bacteria living in our mouths — not by killing them, but by interrupting how they “talk” to each other. Researchers found that dental plaque bacteria use chemical signals to coordinate growth, and by blocking those signals, they were able to encourage healthier bacteria while reducing disease-linked microbes tied to gum disease. Even more
What scientists found inside coral reefs could change the future of medicine
Beneath the beauty of coral reefs lies a hidden universe of microbes unlike anything scientists expected. Each coral species supports its own specialized microbial partners, many of which have never been studied before. These microbes produce a stunning variety of chemical compounds with potential uses in medicine and biotech. The discovery highlights just how much is at stake as coral reefs face
Fraudulent citations, blamed on AI hallucinations, are becoming more common in research papers
“Fabricated” citations that do not reference real academic papers are spreading in the literature, polluting the public record of science, a new study found
Doctors warn this popular vitamin may quietly disrupt cancer care
Many cancer patients turn to biotin supplements hoping to restore hair lost during treatment, but experts warn the popular vitamin may do more harm than good. While biotin is often marketed for stronger hair and nails, there’s little evidence it actually helps cancer-related hair loss—and it can dangerously interfere with lab tests. Doctors say the supplement can distort key blood markers, potenti
Scientists find natural compounds that hit COVID-19 from every angle
A little-known tree from Brazil’s Atlantic Forest may hold a surprising weapon against COVID-19. Researchers discovered that compounds called galloylquinic acids, extracted from its leaves, can attack SARS-CoV-2 on multiple fronts—blocking the virus from entering cells, disrupting its replication, and even dampening harmful inflammation. Unlike many antivirals that target just one part of the viru